SPY335.57+1.00 0.30%
DIA278.14+3.52 1.28%
IXIC10,968.36-42.63 -0.39%

Raymond James Maintains Strong Buy on Flexion Therapeutics, Raises Price Target to $28

Raymond James analyst Elliot Wilbur maintains Flexion Therapeutics (NASDAQ:FLXN) with a Strong Buy and raises the price target from $25 to $28.

Benzinga · -

Raymond James analyst Elliot Wilbur maintains Flexion Therapeutics (NASDAQ:FLXN) with a Strong Buy and raises the price target from $25 to $28.